Neurofibromatosis Type 1 (NF1) in Babies
Medically reviewed by Dr. Michael Okonkwo, MD, FAAP · Board-Certified Neonatologist
Content reviewed against published NIH, AAP, Children's Tumor Foundation guidelines
Last reviewed:
If your baby has been diagnosed with or you suspect neurofibromatosis type 1 (nf1) in babies, here is what the evidence says.
The short answer
Neurofibromatosis type 1 (NF1) is one of the most common genetic conditions, affecting about 1 in 2,500 to 3,000 births. It is autosomal dominant, meaning a child needs only one copy of the altered NF1 gene (about half of cases are new mutations with no family history). The hallmark early sign is six or more cafe-au-lait spots larger than 5mm before puberty. NF1 has highly variable severity — many children have mild symptoms, while others develop complications requiring monitoring. Early diagnosis enables proactive surveillance for learning difficulties, vision changes, and tumor growth.
Key takeaways
- Neurofibromatosis type 1 (NF1) is one of the most common genetic conditions, affecting about 1 in 2,500 to 3,000 births. It is autosomal dominant, meaning a child needs only one copy of the altered NF1 gene (about half of cases are new mutations with no family history). The hallmark early sign is six or more cafe-au-lait spots larger than 5mm before puberty. NF1 has highly variable severity — many children have mild symptoms, while others develop complications requiring monitoring. Early diagnosis enables proactive surveillance for learning difficulties, vision changes, and tumor growth.
- Usually normal when: Your baby has fewer than six cafe-au-lait spots, each smaller than 5mm, with no family history of NF1
- Call your doctor if: Your child with NF1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation
- Varies by age — see the age-by-age breakdown below
“Fever itself is not an illness — rather, it is a sign or symptom that the body is fighting an infection. Fever stimulates certain defenses, such as the white blood cells, which attack and destroy invading bacteria.”
Parents everywhere have the same worry. You are doing the right thing by looking into it.
What Parents Should Know
According to NIH, AAP, Children's Tumor Foundation guidelines, neurofibromatosis type 1 (NF1) is one of the most common genetic conditions, affecting about 1 in 2,500 to 3,000 births. It is autosomal dominant, meaning a child needs only one copy of the altered NF1 gene (about half of cases are new mutations with no family history). The hallmark early sign is six or more cafe-au-lait spots larger than 5mm before puberty. NF1 has highly variable severity — many children have mild symptoms, while others develop complications requiring monitoring. Early diagnosis enables proactive surveillance for learning difficulties, vision changes, and tumor growth. At 0-6 months, cafe-au-lait spots are often the first and sometimes only sign of NF1 in infancy. These are flat, uniformly light brown patches present at birth or appearing in the first months of life. Having six or more spots larger than 5mm is the primary diagnostic criterion in young children. If NF1 is suspected, genetic testing for an NF1 gene mutation can confirm the diagnosis. A family history of NF1 in a parent plus cafe-au-lait spots in the infant is highly suggestive, though about half of cases occur without family history. It is generally considered normal when your baby has fewer than six cafe-au-lait spots, each smaller than 5mm, with no family history of NF1. However, you should contact your pediatrician promptly if your child with NF1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation.
Normal vs. Concerning
When to Seek Immediate Care
- Your child with NF1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation
- A known plexiform neurofibroma rapidly increases in size, becomes painful, or changes in texture — this requires urgent evaluation to rule out malignant transformation
- Your child with NF1 develops new neurological symptoms such as persistent headaches, weakness, or numbness
By Age
What to expect by age
0-6 months
Cafe-au-lait spots are often the first and sometimes only sign of NF1 in infancy. These are flat, uniformly light brown patches present at birth or appearing in the first months of life. Having six or more spots larger than 5mm is the primary diagnostic criterion in young children. If NF1 is suspected, genetic testing for an NF1 gene mutation can confirm the diagnosis. A family history of NF1 in a parent plus cafe-au-lait spots in the infant is highly suggestive, though about half of cases occur without family history.
6-18 months
Additional cafe-au-lait spots may appear during this period. Freckling in the axillary (armpit) or inguinal (groin) areas, called Crowe sign, is another diagnostic criterion that may emerge. Plexiform neurofibromas — diffuse, soft lumps that can grow along nerves — may occasionally be present at birth or become apparent in infancy, though they are more commonly noticed later. Annual ophthalmologic examinations begin to screen for optic pathway gliomas (tumors of the optic nerve), which occur in about 15% of children with NF1.
18 months - 5 years
Lisch nodules (small, harmless bumps on the iris) may begin to appear but are typically not detected until later childhood. Optic pathway gliomas are most likely to cause symptoms during this period, so annual eye exams are critical. Signs of an optic glioma include bulging of the eye, decreased vision, or the child not tracking objects normally. Learning and attention difficulties affect up to 60-80% of children with NF1, so early developmental and educational assessments are recommended.
5+ years
Neurofibromas (benign nerve sheath tumors) typically begin to appear during later childhood and adolescence. Most are dermal neurofibromas — small, soft bumps on or under the skin that are not dangerous. Plexiform neurofibromas require monitoring as they can rarely transform into malignant peripheral nerve sheath tumors (MPNST). Scoliosis and tibial dysplasia (bowing of the shin bone) are skeletal complications to monitor. The MEK inhibitor selumetinib (Koselugo) is now FDA-approved for symptomatic, inoperable plexiform neurofibromas in children. Ongoing multidisciplinary care at an NF clinic provides coordinated monitoring.
What to Tell Your Pediatrician
- Describe when you first noticed neurofibromatosis type 1 (nf1) in babies and how it has changed over time.
- Note your baby's current age and which age-specific patterns you are seeing.
- Mention if your baby has six or more cafe-au-lait spots larger than 5mm — this is the key diagnostic threshold.
- Mention if you notice freckling in your baby's armpits, groin, or neck creases.
- Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
- Bring a list of any questions or observations you want to discuss at the appointment.
What Should You Do?
When to take action
- Your baby has fewer than six cafe-au-lait spots, each smaller than 5mm, with no family history of NF1
- Your baby has been evaluated for NF1 and genetic testing was negative
- Your child has NF1 with only cafe-au-lait spots and is meeting developmental milestones normally
- Your child has a mild NF1 presentation with no tumors, normal vision, and normal learning
- Your baby has six or more cafe-au-lait spots larger than 5mm — this is the key diagnostic threshold
- You notice freckling in your baby's armpits, groin, or neck creases
- You or your partner have NF1 and want your baby evaluated
- Your child with known NF1 is having learning or attention difficulties in school
- Your child with NF1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation
- A known plexiform neurofibroma rapidly increases in size, becomes painful, or changes in texture — this requires urgent evaluation to rule out malignant transformation
- Your child with NF1 develops new neurological symptoms such as persistent headaches, weakness, or numbness
What You Can Do at Home
- Keep track of when you notice neurofibromatosis type 1 (nf1) in babies — noting the time of day, duration, and any triggers can help your pediatrician.
- Remember that your baby has fewer than six cafe-au-lait spots, each smaller than 5mm, with no family history of NF1 — this is generally within the range of normal.
- At 0-6 months, focus on observation rather than intervention unless your pediatrician advises otherwise.
- Follow any care instructions from your pediatrician. Keep a written log of symptoms to bring to appointments.
- While monitoring at home, seek immediate care if your child with NF1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation.
Related Conditions
My Baby Has Light Brown Spots
Café-au-lait spots are flat, light brown birthmarks that are very common and usually harmless. One or two spots are present in about 20-30% of all babies. However, having six or more spots larger than 5mm may be a sign of neurofibromatosis, so your pediatrician will monitor the number and size of spots over time.
Recognizing Signs of a Brain Tumor in Babies and Toddlers
Brain tumors are the second most common childhood cancer after leukemia. In babies and toddlers, symptoms can be subtle and overlap with common childhood complaints. Key warning signs include persistent morning vomiting (especially without nausea), rapidly increasing head size, bulging fontanelle, new-onset seizures, developmental regression, balance and coordination problems, vision changes, and persistent headache. These symptoms are usually caused by other conditions, but persistent or progressive symptoms deserve medical evaluation.
Related Resources
Frequently asked questions
Is neurofibromatosis type 1 (nf1) in babies normal?
When should I call the doctor about neurofibromatosis type 1 (nf1) in babies?
When is neurofibromatosis type 1 (nf1) in babies normal?
What causes neurofibromatosis type 1 (nf1) in babies?
What should I mention to my pediatrician about neurofibromatosis type 1 (nf1) in babies?
Is neurofibromatosis type 1 (nf1) in babies normal at 0-6 months?
Is neurofibromatosis type 1 (nf1) in babies normal at 6-18 months?
Should I go to the ER for neurofibromatosis type 1 (nf1) in babies?
Does neurofibromatosis type 1 (nf1) in babies go away on its own?
References
- [1]National Institute of Neurological Disorders and Stroke. Neurofibromatosis Fact Sheet. NINDS, 2023. NIH
- [2]Miller DT, Freedenberg D, Schorry E, et al. Health Supervision for Children With Neurofibromatosis Type 1. Pediatrics. 2019;143(5):e20190660. AAP
- [3]Children's Tumor Foundation. NF1 Fact Sheet. CTF, 2024. Children's Tumor Foundation
Doctor Visit Checklist
Bring this checklist to your next pediatrician visit to discuss Neurofibromatosis Type 1 (NF1) in Babies.
Things to mention
- Describe when you first noticed neurofibromatosis type 1 (nf1) in babies and how it has changed over time.
- Note your baby's current age and which age-specific patterns you are seeing.
- Mention if your baby has six or more cafe-au-lait spots larger than 5mm — this is the key diagnostic threshold.
- Mention if you notice freckling in your baby's armpits, groin, or neck creases.
- Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
- Bring a list of any questions or observations you want to discuss at the appointment.
Observations to share
- Your baby has six or more cafe-au-lait spots larger than 5mm — this is the key diagnostic threshold
- You notice freckling in your baby's armpits, groin, or neck creases
- You or your partner have NF1 and want your baby evaluated
Urgent signs to report immediately
- Your child with NF1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation
- A known plexiform neurofibroma rapidly increases in size, becomes painful, or changes in texture — this requires urgent evaluation to rule out malignant transformation
- Your child with NF1 develops new neurological symptoms such as persistent headaches, weakness, or numbness
My notes
From ismybabyalright.com — free, evidence-based baby health guides
All content follows our editorial policy and is reviewed against published clinical guidelines.
2,705 evidence-based guides6 authoritative medical sources5 medical advisory board members
Related Resources
Bottom line
Most cases of neurofibromatosis type 1 (nf1) in babies are normal. Talk to your pediatrician if your child with nf1 develops sudden vision changes, eye bulging, or stops tracking objects — possible optic pathway glioma requiring urgent ophthalmologic and neurological evaluation.
Trust your instincts. If something feels wrong, reach out to your pediatrician. Worrying about your baby means you care — that is a good thing.
Was this page helpful?
Related Medical Concerns
My Baby Has Light Brown Spots
Café-au-lait spots are flat, light brown birthmarks that are very common and usually harmless. One or two spots are present in about 20-30% of all babies. However, having six or more spots larger than 5mm may be a sign of neurofibromatosis, so your pediatrician will monitor the number and size of spots over time.
Recognizing Signs of a Brain Tumor in Babies and Toddlers
Brain tumors are the second most common childhood cancer after leukemia. In babies and toddlers, symptoms can be subtle and overlap with common childhood complaints. Key warning signs include persistent morning vomiting (especially without nausea), rapidly increasing head size, bulging fontanelle, new-onset seizures, developmental regression, balance and coordination problems, vision changes, and persistent headache. These symptoms are usually caused by other conditions, but persistent or progressive symptoms deserve medical evaluation.
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
Adrenoleukodystrophy (ALD) in Babies
X-linked adrenoleukodystrophy (X-ALD) is a genetic disorder affecting about 1 in 17,000 newborns, caused by mutations in the ABCD1 gene on the X chromosome. It primarily affects boys and impairs the breakdown of very long-chain fatty acids (VLCFAs), which accumulate and damage the myelin sheath in the brain and the adrenal glands. The most severe form, cerebral ALD, typically affects boys between ages 4-10 with rapid neurological decline. Newborn screening now enables early detection, and hematopoietic stem cell transplant or gene therapy performed before significant brain involvement can be life-saving.